triparanol has been researched along with Apolipoprotein C-II Deficiency in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
CHERRIER, F; FAIVRE, G; GILGENKRANTZ, JM; HENRY, C | 1 |
SOBRA, J | 1 |
1 review(s) available for triparanol and Apolipoprotein C-II Deficiency
Article | Year |
---|---|
[CONGENITAL DISORDERS OF LIPID METABOLISM. XII. HYPOCHOLESTEREMIC EFFECT OF TRIPARANOL].
Topics: Cholesterol; Hyperlipidemias; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type III; Lipid Metabolism; Lipids; Phospholipids; Toxicology; Triparanol | 1964 |
1 other study(ies) available for triparanol and Apolipoprotein C-II Deficiency
Article | Year |
---|---|
[FAMILIAL XANTHOMATOUS HYPERCHOLESTEREMIA].
Topics: Adrenocorticotropic Hormone; Cortisone; Diagnosis, Differential; Diet; Diet Therapy; Dietary Fats; Estrogens; Genetics, Medical; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Iodine; Niacin; Pathology; Phenylacetates; Thyroid Gland; Tissue Extracts; Triparanol; Xanthomatosis | 1963 |